carbidopa has been researched along with Encephalitis Lethargica Type Parkinsonism in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bopeththa, BVKM; Ralapanawa, U | 1 |
McAuley, J; Shahmanesh, M; Swash, M | 1 |
Adamkov, J; Drobný, M; Fundárek, J; Svaleková, A | 1 |
Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM | 1 |
Barbeau, A | 1 |
5 other study(ies) available for carbidopa and Encephalitis Lethargica Type Parkinsonism
Article | Year |
---|---|
Post encephalitic parkinsonism following dengue viral infection.
Topics: Aged; Antibodies, Viral; Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Immunoglobulin M; Levodopa; Male; Parkinson Disease, Postencephalitic; Severe Dengue; Sri Lanka | 2017 |
Dopaminergic therapy in acute encephalitis lethargica.
Topics: Acute Disease; Adolescent; Apomorphine; Carbidopa; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Parkinson Disease, Postencephalitic | 1999 |
[Therapy of rigidity and hypokinesis in old age using Sinemet].
Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Muscle Rigidity; Parkinson Disease, Postencephalitic; Trihexyphenidyl | 1979 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis | 1977 |
Editorial: Long-term assessment of levodopa therapy in Parkinson's disease.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Parkinson Disease, Postencephalitic | 1975 |